Related Experiment Videos
Ten years follow up study of steroid therapy for congenital encephalomyopathy
Insights
This study describes two boys with congenital muscular dystrophy who showed improvement in motor function and cognitive deficits after treatment with adrenal cortical steroids, suggesting inflammation may play a role.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Congenital muscular dystrophy (CMD) presents at birth with muscle weakness.
- Fukuyama type CMD is a severe form with intellectual disability and specific genetic mutations.
- Inflammatory processes are not typically considered primary causes of CMD.
Observation:
- Two 10-year-old boys presented with congenital myopathy and mental retardation.
- Both exhibited elevated serum creatine phosphokinase (CK) levels.
- Muscle biopsies suggested an inflammatory, rather than purely degenerative, myopathy.
Findings:
- Treatment with adrenal cortical steroids led to a significant decrease in serum CK.
- One patient showed improvement in mental retardation, and the other in motor dysfunction.
- The response to steroids suggests an inflammatory component in their condition.
Implications:
- Inflammation may be a contributing factor in the pathogenesis of some congenital muscular dystrophy cases.
- This finding could open new therapeutic avenues for specific CMD subtypes.
- Further research is warranted to explore the role of inflammatory pathways in CMD.
Abstract:
Two 10-year-old boys with mental retardation and myopathy which were present since birth are described. Both had elevated serum creatine phosphokinase (CK) and one of them had a positive family history. The clinical features were consistent with Fukuyama type congenital muscular dystrophy, but muscle biopsies suggested an inflammatory process. Adrenal cortical steroids were given and they were followed up until 10 years of age. Serum CK showed a significant response to the treatment, and mental retardation in case 1 and motor dysfunction in case 2 improved. It is postulated that an inflammatory process might be a causative factor in some patients with congenital muscular dystrophy.